HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

T Hünig Selected Research

Therapeutics

11/2005Superagonistic anti-CD28 antibodies: potent activators of regulatory T cells for the therapy of autoimmune diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


T Hünig Research Topics

Disease

1Cytokine Release Syndrome
10/2010
1Azotemia
10/2008
1Autoimmune Diseases (Autoimmune Disease)
11/2005

Drug/Important Bio-Agent (IBA)

1TGN-1412 (TGN1412)IBA
10/2010
1Immunoglobulin G (IgG)IBA
10/2008
1AntibodiesIBA
11/2005

Therapy/Procedure

1Therapeutics
11/2005